Geneseeq
Nanjing, CN · 2 known investors
Find your way into Geneseeq
Sign up to find every way you can get introduced to Geneseeq
- Your email: who you already know at Geneseeq, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Geneseeq team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Geneseeq develops next-generation sequencing (NGS) based genetic tests and in-vitro diagnostic products for cancer patients, using gene profiling to guide targeted drug selection, indicate drug resistance mechanisms, and monitor post-surgical recurrence. It also works on early cancer screening and provides molecular diagnostic services and pharmaceutical partnership/companion diagnostics for precision oncology.
Investors · 2
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
How we know: the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountC roundJul 2017Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Geneseeq do?
- Geneseeq develops next-generation sequencing (NGS) based genetic tests and in-vitro diagnostic products for cancer patients, using gene profiling to guide targeted drug selection, indicate drug resistance mechanisms, and monitor post-surgical recurrence. It also works on early cancer screening and provides molecular diagnostic services and pharmaceutical partnership/companion diagnostics for precision oncology.
- Who are Geneseeq's investors?
- Geneseeq's investors include LAV, Lilly Asia Ventures.
- Where is Geneseeq headquartered?
- Geneseeq is headquartered in Nanjing, CN.
